Medicare Drug Price Negotiations Expose Community Pharmacies to Financial Risk
Drug Topics
JANUARY 30, 2025
A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Acts Medicare Drug Price Negotiation Program.
Thu.Jan 30, 2025
228 
FDA Approves Suzetrigine, New Alternative to Opioids for Acute Pain
Pharmacy Times
JANUARY 30, 2025
The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Fierce Healthcare - Untitled Article
Fierce Healthcare
JANUARY 30, 2025
Sen. Bill Cassidy, chair of the Senate HELP Committee, and ranking member Bernie Sanders were aligned on their concerns about Kennedy's approach to vaccines. With a vote on Kennedys nomination to take place in the Senate Finance Committee next week, Cassidy, who also sits on that committee, said hes going to have to use the weekend to make up his mind.
Digoxin Effectively Reduces Circulating Tumor Cell Clusters in Metastatic Breast Cancer, Study Finds
Pharmacy Times
JANUARY 30, 2025
Digoxen is the active ingredient found in the foxglove plant and is commonly used to treat heart failure.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare - Untitled Article
Fierce Healthcare
JANUARY 30, 2025
Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high costs members may face. | Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high costs members may face.
New Research Explains Why Immunotherapy Is Less Effective in Children With Cancer
Pharmacy Times
JANUARY 30, 2025
Children and adults with cancer have differing immune system responses, mutational burdens, and tissue microenvironments.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
FDA Approves Symbravo for Acute Treatment of Migraine With or Without Aura
Pharmacy Times
JANUARY 30, 2025
Meloxicam and rizatriptan reduces migraine pain and help patients return to normal functioning with efficacy through 24 to 48 hours after a single dose for some patients.
Fierce Healthcare - Untitled Article
Fierce Healthcare
JANUARY 30, 2025
The Cigna Group reported $1.4 billion in profit for the fourth quarter of 2024, falling short of Wall Street's expectations as it was dinged by elevated medical costs that continue to plague the industry.
Predictors of Blinatumomab Therapy Failure and CD19-Negative Relapse in Adult B-Cell ALL
Pharmacy Times
JANUARY 30, 2025
Leukemia biology may predict patterns of blinatumomab failure after initial response.
FDA Approves Suzetrigine For Treatment of Acute Pain
Drug Topics
JANUARY 30, 2025
The decision makes the selective NaV1.8 pain signal inhibitor the first new class of medicine to treat acute pain in over 20 years.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Inavolisib in Combination With Palbociclib and Fulvestrant Meets Secondary End Point in the INAVO120 Trial
Pharmacy Times
JANUARY 30, 2025
The overall survival data were immature at the primary analysis of the study.
ASHP’s Outlook for the Pharmacy Profession in 2025
Drug Topics
JANUARY 30, 2025
Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.
Strategies and Opportunities to Enhance Pharmacists’ Role in Hyperkalemia Management
Pharmacy Times
JANUARY 30, 2025
Pharmacists can improve hyperkalemia management through collaboration and innovation.
Diabetes, Prediabetes Linked to Older Brain Age
Drug Topics
JANUARY 30, 2025
Patients with diabetes and prediabetes have older brain ages than their chronological age compared with normoglycemic patients.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Study: Radiotherapeutic Agent for GEP-NETs Demonstrates Positive Results
Pharmacy Times
JANUARY 30, 2025
Lu-edotreotide (ITM-11; ITM) met its primary endpoint of prolonging progression-free survival (PFS).
Racial Disparities Significant in Children Receiving Nutrition, Lifestyle Counseling
Drug Topics
JANUARY 30, 2025
In a post hoc secondary analysis of the BP-CATCH trial, researchers explored the best ways of screening children with high blood pressure and managing their care.
Employee Terminated for Being Impaired by Medicinal Marijuana at Work
Pharmacy Times
JANUARY 30, 2025
The court also addressed the employers basis for ordering a drug test.
Key trends shaping pharmaceutical operations in 2025
pharmaphorum
JANUARY 30, 2025
Stay ahead of the curve by exploring the key trends shaping pharmaceutical operations in 2025, including cybersecurity, efficiency, workforce management, and technology advancements. Learn more about these important industry developments.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Trametinib Reduces in Mortality, Morbidity for Children With Hypertrophic Cardiomyopathy
Pharmacy Times
JANUARY 30, 2025
Hypertrophic cardiomyopathy is caused by abnormal genes in the heart muscle, causing the left ventricle to become thicker and effecting blood flow.
Could an ECG spot people at risk of cognitive decline?
pharmaphorum
JANUARY 30, 2025
UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI
Red Cell Distribution Width Could Predict Anemia in Ruxolitinib-Treated Patients With Myelofibrosis
Pharmacy Times
JANUARY 30, 2025
Diagnosing anemia, a serious and common complication of patients with myelofibrosis, could be made easier with the use of red cell distribution width assessment.
Cargo to lay off staff after CAR-T data show safety concerns
STAT
JANUARY 30, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at RFK Jr.’s first day of confirmation hearings and the latest biotech news.
Childhood-Onset Epilepsy Is Associated With Amyloid Accumulation in Late Adulthood
Pharmacy Times
JANUARY 30, 2025
Additionally, the authors observe that childhood-onset epilepsy is associated with an earlier age at the onset of amyloidosis.
What your mouth might say about your stroke risk
STAT
JANUARY 30, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! It’s Thursday. Friday eve. Can you believe it?
Navigating the Enhanced Oncology Model: Insights and Strategies From American Oncology Network
Pharmacy Times
JANUARY 30, 2025
Melody Chang, RPh, MBA, BCOP, explains how American Oncology Network leveraged its experience with the Oncology Care Model to address challenges when adopting the Enhanced Oncology Model.
Fierce Healthcare - Untitled Article
Fierce Healthcare
JANUARY 30, 2025
Follow along today for ongoing coverage of Robert F. Kennedy Jr.'s second Senate confirmation hearing. | Follow along today for ongoing coverage of Robert F Kennedy Jr.'s second Senate confirmation hearing.
Scholar Rock Submits FDA Application for Apitegromab to Improve Motor Function in Spinal Muscular Atrophy
Pharmacy Times
JANUARY 30, 2025
Apitegromab is a muscle-targeted therapy for improvement of motor function in individuals with spinal muscular atrophy.
MHRA launches refreshed ILAP to speed up NHS drug access
Pharmaceutical Technology
JANUARY 30, 2025
The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.
Belzutifan Receives FDA Priority Review for Advanced Pheochromocytoma and Paraganglioma
Pharmacy Times
JANUARY 30, 2025
The supplemental new drug application is based on objective response rate and duration of response results from a phase 2 study that assessed the efficacy and safety of belzutifan.
Takeda announces appointment of Julie Kim as CEO
Pharmaceutical Technology
JANUARY 30, 2025
Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.
Dust mite allergy sufferers set for a new NHS treatment
pharmaphorum
JANUARY 30, 2025
ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales, and Northern Ireland, but not in Scotland.
Leveragen and Moonlight Bio unite for T-cell therapy development
Pharmaceutical Technology
JANUARY 30, 2025
Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers.
Takeda CEO succession confirmed as Weber plans retirement
pharmaphorum
JANUARY 30, 2025
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.
Let's personalize your content